DaShenLin Pharmaceutical Group Co., Ltd. Stock: price and insider trades · China
大参林
DaShenLin Pharmaceutical Group Co., Ltd.: what insiders have been doing
Only a handful of insider records exist for DaShenLin Pharmaceutical Group Co., Ltd., the last one from 16 August 2023, too few to describe a trend. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 63,500 shares100.0% of flowA股XSHGSSE:173000006811461440
1 of 1 declaration
About DaShenLin Pharmaceutical Group Co., Ltd.
大参林 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the distribution of pharmaceutical and healthcare products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
